- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 471.7953 ↓ -1.46%
[as on 2 April, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH and its peers as on 2 April, 2026
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | -12.62% | 2.71% | -8.64% | 0.65% | 68.71% | 20.05% | -4.78% | 40.03% | 43.86% | -2.89% |
Discrete returns (monthly)
| Month | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 |
|---|
| Returns | 3.53% | 2.35% | -1.12% | -1.93% | 2.61% | 0.63% | -2.82% | -3.5% | 6.36% | -3.54% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | 14.7% | -0.61% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 95.82% |
0.07% (Arbitrage: 0.00%) |
0.00% |
0.00% |
4.11% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.97% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.90% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 5.63% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.45% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.23% |
| Acutaas Chemicals Ltd. | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 4.00% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.60% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.50% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 3.34% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.25% |
| Jupiter Life Line Hospitals Ltd. | JLHL (INE682M01012) | Healthcare Services | 3.21% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 3.09% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.98% |
| Aether Industries Ltd. | AETHER (INE0BWX01014) | Chemicals & Petrochemicals | 2.97% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.94% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.91% |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 2.90% |
| Polymedicure Ltd. | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 2.82% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.75% |
| Concord Biotech Ltd. | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 2.47% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.08% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 2.00% |
| Cohance Lifesciences Ltd. | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 1.64% |
| Vijaya Diagnostic Centre Ltd. | VIJAYA (INE043W01024) | Healthcare Services | 1.45% |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.20% |
| Medplus Health Services Ltd. | MEDPLUS (INE804L01022) | Retailing | 0.98% |
| Gufic Biosciences Ltd. | GUFICBIO (INE742B01025) | Pharmaceuticals & Biotechnology | 0.86% |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 0.85% |
| Sudeep Pharma Ltd. | INE0QPI01025 | Pharmaceuticals & Biotechnology | 0.72% |
| Rainbow Children's Medicare Ltd. | RAINBOW (INE961O01016) | Healthcare Services | 0.12% |
| Lonza Group | US54338V1017 | Pharmaceuticals & Biotechnology | 4.01% |
Debt
| Name | Rating | Weight % |
|---|
| 364 DAY T-BILL 19.11.26 | Sovereign | 0.07% |
Portfolio data is as on date 30 November, 2025
NAV history
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 2 April, 2026 | 471.7953 | -1.46% |
| 1 April, 2026 | 478.8006 | -0.16% |
| 31 March, 2026 | 479.5473 | 0.07% |
| 30 March, 2026 | 479.2058 | -1.37% |
| 27 March, 2026 | 485.8430 | -0.47% |
| 25 March, 2026 | 488.1308 | 1.53% |
| 24 March, 2026 | 480.7764 | 2.15% |
| 23 March, 2026 | 470.6782 | -2.19% |
| 20 March, 2026 | 481.2159 | 1.55% |
| 19 March, 2026 | 473.8545 | -2.21% |
| 18 March, 2026 | 484.5506 | 0.71% |
| 17 March, 2026 | 481.1509 | 0.67% |
| 16 March, 2026 | 477.9712 | -0.64% |
| 13 March, 2026 | 481.0413 | -2.16% |
| 12 March, 2026 | 491.6384 | -0.53% |
| 11 March, 2026 | 494.2357 | -0.08% |
| 10 March, 2026 | 494.6432 | 1.05% |
| 9 March, 2026 | 489.4889 | -0.93% |
| 6 March, 2026 | 494.0722 | -0.09% |
| 5 March, 2026 | 494.5377 | 1.2% |
| 4 March, 2026 | 488.6753 | -1.19% |
| 2 March, 2026 | 494.5663 | -0.51% |
| 28 February, 2026 | 497.1239 | 0% |
| 27 February, 2026 | 497.1341 | -1.02% |
| 26 February, 2026 | 502.2457 | 1.17% |
| 25 February, 2026 | 496.4320 | 1.46% |
| 24 February, 2026 | 489.3047 | 0.27% |
| 23 February, 2026 | 487.9716 | 0.61% |
| 20 February, 2026 | 485.0003 | -0.17% |
| 19 February, 2026 | 485.8417 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The latest NAV of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH is 471.7953 as on 2 April, 2026.
What are YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are -2.59% as on 2 April, 2026.
What are 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 2.04% as on 2 April, 2026.
What are 3 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 3 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 24.8% as on 2 April, 2026.
What are 5 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 5 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 16.98% as on 2 April, 2026.
What are 10 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 10 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 16.98% as on 2 April, 2026.
